Skip to content
Peptide Therapeutics intermediate

Breast Cancer: Oligopeptide Research Reference

Malignant proliferation of breast epithelial cells. Most common cancer in women worldwide. Molecular subtypes: Luminal A (ER+/PR+/HER2-, best prognosis), Lum...

By Encyclopeptide Editorial | 1 min read
breast-cancer peptide research

Overview

Malignant proliferation of breast epithelial cells. Most common cancer in women worldwide. Molecular subtypes: Luminal A (ER+/PR+/HER2-, best prognosis), Lum…ched (ER-/HER2+, aggressive but targetable), Triple-negative (ER-/PR-/HER2-, worst prognosis). Risk factors: age, BRCA1/2 mutations, family history, hormone exposure. Treatments: surgery, radiation, endocrine therapy, HER2-targeted therapy, CDK4/6 inhibitors, immunotherapy.

Clinical Significance

This molecule has important therapeutic or diagnostic applications in clinical medicine.

References

  1. Encyclopeptide Database. “Breast Cancer” monograph. encyclopeptide.com.

Test Your Knowledge

Reinforce what you learned about Breast Cancer: Oligopeptide Research Reference with interactive quizzes on Wikipept.

Take a Quiz on Wikipept